Abstract:Importance: Prenatal opioid exposure (POE) is one of the fastest-growing global health problems, but its association with long-term neurologic and physical development remains unknown.Objective: To assess the association between POE and cognitive and motor development in children from age 6 months to 18 years.Data Sources: Key search terms included prenatal opioid exposure, neonatal abstinence syndrome, and neurocognitive development. Studies were searched using PubMed and Embase, with no publication date restriction, through August 20, 2018.Study Selection: Only published cohort studies comparing the results of age-appropriate standardized cognitive and/or motor tests between children with any POE (aged 0-18 years) with drug-free controls were included. Data that were not convertible to means and SDs were excluded.Data Extraction and Synthesis: This study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Data were pooled using a random-effects model.Main Outcomes and Measures: Standardized mean difference of cognitive and motor tests between POE and nonexposed children.Results: Twenty-six peer-reviewed cohort studies were included. Cognitive outcomes were compared for a total of 1455 children with POE and 2982 nonexposed children across 3 age groups (mean [SE] age at cognitive testing was 13 [1.58] months for the toddler group; 4.5 [0.38] years for the preschool group; and 13 [2.36] years for the school-aged group). Motor outcomes were compared for 688 children with POE and 1500 nonexposed children up to age 6 years (mean [SD] age at motor testing, 2 [0.45] years). Standardized mean difference was lower in cognitive tests for children with POE at 0 to 2 years (d = -0.52; 95% CI, -0.74 to -0.31; P < .001) and 3 to 6 years (d = -0.38; 95% CI, -0.69 to -0.07; P < .001); the difference was not significant for those aged 7 to 18 years (d = -0.44; 95% CI, -1.16 to 0.28; P = .23). Motor scores were lower in children with POE (d = 0.49; 95% CI, 0.23-0.74; P < .001).Conclusions and Relevance: Prenatal opioid exposure appeared to be negatively associated with neurocognitive and physical development from age 6 months, and this association persisted until adolescence. The cause and association of this with POE or other factors (eg, withdrawal treatment) are uncertain but suggest that POE necessitates long-term support and intervention.

Association of Postnatal Opioid Exposure and 2-Year Neurodevelopmental Outcomes in Infants Undergoing Cardiac Surgery

[Perioperative Anesthetic Exposure and the Neurodevelopmental Status of 1 Year Old Baby Underwent Neonatal Cardiac Surgery].

Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study

Molecular and Long-Term Behavioral Consequences of Neonatal Opioid Exposure and Withdrawal in Mice.

A Minimal Opioid Postoperative Management Protocol in Congenital Cardiac Surgery: Safe and Effective

Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants

Prenatal exposure to opioids and neurodevelopment in infancy and childhood: A systematic review

Opioid exposure in gestation, postnatal adversity, and preschool-age cognitive functioning

Effect of Neonatal Perioperative Anesthetic Exposure in Cardiac Surgery on Neuro-Developmental Outcomes in Preschool Children

A Prospective Multi-Institutional Study Comparing the Brain Development in the Third Trimester between Opioid-Exposed and Nonexposed Fetuses Using Advanced Fetal MR Imaging Techniques

The Cost of Opioid Use in High-Risk Hospitalized Infants

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population-based study

Global Brain Functional Network Connectivity in Infants With Prenatal Opioid Exposure

Quantitative Pupillometry As a Predictor of Pediatric Postoperative Opioid-Induced Respiratory Depression.

Prenatal Opioid Exposure and Risk for Adverse Brain and Motor Outcomes in Infants Born Premature

Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure

Can Perioperative Electroencephalogram and Adverse Hemodynamic Events Predict Neurodevelopmental Outcomes in Infants with Congenital Heart Disease?

The Association of Preoperative Opioid Use with Post-Discharge Outcomes

Predictors of Postoperative Morphine Milligram Equivalents in Cardiac Surgery

Prenatal methadone exposure and child developmental outcomes in 2-year-old children

Impact of postoperative necrotizing enterocolitis after neonatal cardiac surgery on neurodevelopmental outcome at 1 year of age